Courtney McQueen's Archive

courtney.mcqueen@light-kr.com

 Courtney McQueen joined the Light Knowledge Resources team as a writer and managing editor in May 2009, and as an associate publisher in May 2010. Courtney has a B.S. in Chemistry from Harvey Mudd College in California and a Ph.D. in Chemistry from Princeton University. At LKR, she helps manage and develop the Beacon websites. In her spare time, she enjoys reading, watching Mythbusters, cooking, and spending time with her family.

Courtney McQueen has written 14 article(s).

Researchers Present Early Data On New Treatment Approaches And Drugs For HIV (AIDS 2010)
[ by Mariana Plazas-Mayorca and Courtney McQueen | Jul 22, 2010 1:30 pm | No Comments ]
Researchers Present Early Data On New Treatment Approaches And Drugs For HIV (AIDS 2010)

Several innovative but preliminary treatment approaches were presented Monday at the 2010 International AIDS Conference currently underway in Vienna, Austria. Presentations included the results of animal and laboratory studies on novel drugs and new generations of traditional therapies.

Two of the studies focused on methods to completely eliminate HIV from the body. More specifically, they targeted latent HIV – HIV that lies dormant in infected cells and can start multiplying again if antiretroviral therapy is stopped.

Latent HIV is difficult…

Read the full story »
Study Finds Rate Of HIV Progression Is Linked To Human And Virus Genetics
[ by Mariana Plazas-Mayorca and Courtney McQueen | Jul 6, 2010 5:55 pm | No Comments ]
Study Finds Rate Of HIV Progression Is Linked To Human And Virus Genetics

A study published this month in the journal PLoS One shows that how quickly an HIV infection turns into AIDS is linked to a specific set of human genes as well as certain genes of the virus. The research confirms earlier studies that showed human genetics can be important for disease progression. The new research also shows more clearly how genes of the virus influence HIV infection.

HIV infections can vary widely in the amount of time they take to…

Read the full story »
FDA Advisory Committee Recommends Approval For Tesamorelin
[ by Courtney McQueen and Shruti Kalra | May 28, 2010 4:12 am | No Comments ]
FDA Advisory Committee Recommends Approval For Tesamorelin

In a 16-0 vote yesterday, a U.S. Food and Drug Administration (FDA) advisory committee recommended that the drug tesamorelin be approved for the treatment of HIV-associated lipodystrophy.

Although the FDA is not required to follow the recommendations of its advisory committees, it usually does.

Tesamorelin is being developed by Montreal-based Theratechnologies Inc. If approved, the drug would be marketed in the United States by EMD Serono, a unit of the German pharmaceutical company Merck KGaA. The proposed brand name for tesamorelin is Egrifta.

“I think that…

Read the full story »
Scientists Reveal New Keys To HIV Progression
[ by Kieryn Graham and Courtney McQueen | May 19, 2010 2:10 pm | No Comments ]
Scientists Reveal New Keys To HIV Progression

For most diseases, having a robust, healthy immune response is critical to keeping invading microbes in check.

For HIV, scientists are increasingly realizing that an activated immune system is not necessarily a good thing. In fact, it seems to be a key to viral replication and disease progression.

“Disease associated with chronic infections such as HIV may not be so much a result of the virus attacking the host,” wrote researchers in an article released today in Science Translational Medicine,…

Read the full story »
Page 1 of 41234»